Rhythmic flashing light, or “Ganzflicker”, can elicit altered states of consciousness and hallucinations, bringing your mind’s eye out into the real world. What do you experience if you have a super mind’s eye, or none at all? In this talk, I will discuss how Ganzflicker has been used to simulate psychedelic experiences, how it can help us predict symptoms of psychosis, and even tap into the neural basis of hallucinations.

This talk aims to highlight the immense potential of Artificial Intelligence (AI) in advancing the field of psychology and cognitive neuroscience. Through the integration of machine learning algorithms, big data analytics, and neuroimaging techniques, AI has the potential to revolutionize the way we study human cognition and brain characteristics. In this talk, I will highlight our latest scientific advancements in utilizing AI to gain deeper insights into variations in cognitive performance across the lifespan and along the continuum from healthy to pathological functioning. The presentation will showcase cutting-edge examples of AI-driven applications, such as deep learning for automated scoring of neuropsychological tests, natural language processing to characeterize semantic coherence of patients with psychosis, and other application to diagnose and treat psychiatric and neurological disorders. Furthermore, the talk will address the challenges and ethical considerations associated with using AI in psychological research, such as data privacy, bias, and interpretability. Finally, the talk will discuss future directions and opportunities for further advancements in this dynamic field.

Humans constantly make perceptual decisions on human faces and voices. These regularly come with the challenge of receiving only uncertain sensory evidence, resulting from noisy input and noisy neural processes. Efficiently adapting one’s internal decision system including prior expectations and subsequent metacognitive assessments to these challenges is crucial in everyday life. However, the exact decision mechanisms and whether these represent modifiable states remain unknown in the general population and clinical patients with psychosis. Using data from a laboratory-based sample of healthy controls and patients with psychosis as well as a complementary, large online sample of healthy controls, I will demonstrate how a combination of perceptual face and voice recognition decision fidelity, metacognitive ratings, and Bayesian computational modelling may be used as indicators to differentiate between non-clinical and clinical states in the future.